These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 8998122)
1. Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Habel LA; Moe RE; Daling JR; Holte S; Rossing MA; Weiss NS Ann Surg; 1997 Jan; 225(1):69-75. PubMed ID: 8998122 [TBL] [Abstract][Full Text] [Related]
2. Epidemiological survey of preinvasive breast cancer. Vandenbroucke A; Bourdon C Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():3-10. PubMed ID: 8298449 [TBL] [Abstract][Full Text] [Related]
3. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Li CI; Malone KE; Saltzman BS; Daling JR Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564 [TBL] [Abstract][Full Text] [Related]
4. Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ. Miller ME; Muhsen S; Zabor EC; Flynn J; Olcese C; Giri D; Van Zee KJ; Pilewskie M Ann Surg Oncol; 2019 Dec; 26(13):4317-4325. PubMed ID: 31552614 [TBL] [Abstract][Full Text] [Related]
5. The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry. Claus EB; Stowe M; Carter D; Holford T Breast; 2003 Dec; 12(6):451-6. PubMed ID: 14659121 [TBL] [Abstract][Full Text] [Related]
6. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Ottesen GL; Graversen HP; Blichert-Toft M; Christensen IJ; Andersen JA Breast Cancer Res Treat; 2000 Aug; 62(3):197-210. PubMed ID: 11072784 [TBL] [Abstract][Full Text] [Related]
7. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy. Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852 [TBL] [Abstract][Full Text] [Related]
8. Is there a low-grade precursor pathway in breast cancer? King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747 [TBL] [Abstract][Full Text] [Related]
9. The Pathologic Finding of Combined Lobular Carcinoma Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858 [TBL] [Abstract][Full Text] [Related]
10. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Renshaw AA; Gould EW Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205 [TBL] [Abstract][Full Text] [Related]
11. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ. Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343 [TBL] [Abstract][Full Text] [Related]
12. Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study. Mullooly M; Khodr ZG; Dallal CM; Nyante SJ; Sherman ME; Falk R; Liao LM; Love J; Brinton LA; Gierach GL Am J Epidemiol; 2017 Dec; 186(12):1329-1340. PubMed ID: 28637226 [TBL] [Abstract][Full Text] [Related]
13. Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ? Minami CA; Zabor EC; Gilbert E; Newman A; Park A; Jochelson MS; King TA; Pilewskie ML Ann Surg Oncol; 2020 Jun; 27(6):1844-1851. PubMed ID: 31898097 [TBL] [Abstract][Full Text] [Related]
14. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Li CI; Daling JR; Malone KE Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180 [TBL] [Abstract][Full Text] [Related]
15. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ. Wong SM; King T; Boileau JF; Barry WT; Golshan M Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673 [TBL] [Abstract][Full Text] [Related]
16. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up. Ringberg A; Andersson I; Aspegren K; Linell F Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650 [TBL] [Abstract][Full Text] [Related]
17. Family history of breast and ovarian cancer and the risk of breast carcinoma in situ. Claus EB; Stowe M; Carter D Breast Cancer Res Treat; 2003 Mar; 78(1):7-15. PubMed ID: 12611452 [TBL] [Abstract][Full Text] [Related]
18. Trends of in situ carcinoma of the breast in Vaud, Switzerland. Levi F; Te VC; Randimbison L; La Vecchia C Eur J Cancer; 1997 May; 33(6):903-6. PubMed ID: 9291813 [TBL] [Abstract][Full Text] [Related]
19. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122 [TBL] [Abstract][Full Text] [Related]
20. Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Ottesen GL; Graversen HP; Blichert-Toft M; Zedeler K; Andersen JA Am J Surg Pathol; 1993 Jan; 17(1):14-21. PubMed ID: 8383466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]